One of the most used nootropics. The only drug reported to cause lipofuscin regression. Has a unique mechanism of action, used in cases of cerebral insufficiency, dementia, stroke, and cerebral aging.
Cerebral insufficiency is general deterioration of brain functions, characterized by memory deficits and behavioral changes.
It can occur by aging or as a result of strokes, traumas or even cerebral atherosclerosis.
Lucidril 250 mg Active Ingredient:
Meclofenoxate Hydrochloride (freeze-dried)………………250 mg
2 tablets in the morning, 2 tablets at noon (before 4 O'clock p.m.) in repeated courses, not less than one month.
The degree of action of Lucidril is very largely dependent upon the duration of treatment.
leaflet lucidril 250.pdf
Tebonina is a Ginkgo extract with no exact mechanism of action, simply a brain tonic and anti-oxidant!!!
While lucidril acts specifically on acetylcholine … To objectively improve brain function together with its lipofuscinolytic action.
No known interactions.
Minapharm Pharmaceuticals receives regulatory approval from the Paul-Ehrlich Institute for a phase 1 multi-center clinical trial in Germany for its Adalimumab biosimilar
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement
for the Commercialization of Multiple Biosimilar Candidates of Alvotech
in the Middle East and Africa
As a global leader in biotechnology & cellular engineering, ProBioGen-Minapharm
As a continuation of Minapharm unique series of "Expert Panel",
The meeting was chaired by Prof. Abdel-Shakour EL MOHAMADY.
The First Netilmicin The Least Resistance
The First Netilmicin Combination the Quick Relief for Ocular Inflammation
Striking Glaucoma Treatment Goals Balancing EFFICACY, COMPLIANCE & AFFORADABILITY
Robust & long lasting correction of serum vitamin D levels For prophylaxis and/or treatment of vitamin D deficiency
Stay connected, subscribe to our newsletter for news and updates.